News
Two studies reveal promising treatments for breast cancer, enhancing options for patients with triple-negative breast cancer ...
Dr. David Morris presented results from the TRITON3 study of rucaparib versus docetaxel or a second-generation androgen receptor pathway inhibitor (ARPI) in metastatic castrate-resistant prostate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback